304 related articles for article (PubMed ID: 24487962)
1. USP11 regulates PML stability to control Notch-induced malignancy in brain tumours.
Wu HC; Lin YC; Liu CH; Chung HC; Wang YT; Lin YW; Ma HI; Tu PH; Lawler SE; Chen RH
Nat Commun; 2014; 5():3214. PubMed ID: 24487962
[TBL] [Abstract][Full Text] [Related]
2. SCP phosphatases suppress renal cell carcinoma by stabilizing PML and inhibiting mTOR/HIF signaling.
Lin YC; Lu LT; Chen HY; Duan X; Lin X; Feng XH; Tang MJ; Chen RH
Cancer Res; 2014 Dec; 74(23):6935-46. PubMed ID: 25293974
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-specific Protease 11 (USP11) Deubiquitinates Hybrid Small Ubiquitin-like Modifier (SUMO)-Ubiquitin Chains to Counteract RING Finger Protein 4 (RNF4).
Hendriks IA; Schimmel J; Eifler K; Olsen JV; Vertegaal ACO
J Biol Chem; 2015 Jun; 290(25):15526-15537. PubMed ID: 25969536
[TBL] [Abstract][Full Text] [Related]
4. TRIM32/USP11 Balances ARID1A Stability and the Oncogenic/Tumor-Suppressive Status of Squamous Cell Carcinoma.
Luo Q; Wu X; Nan Y; Chang W; Zhao P; Zhang Y; Su D; Liu Z
Cell Rep; 2020 Jan; 30(1):98-111.e5. PubMed ID: 31914402
[TBL] [Abstract][Full Text] [Related]
5. KLHL39 suppresses colon cancer metastasis by blocking KLHL20-mediated PML and DAPK ubiquitination.
Chen HY; Hu JY; Chen TH; Lin YC; Liu X; Lin MY; Lang YD; Yen Y; Chen RH
Oncogene; 2015 Oct; 34(40):5141-51. PubMed ID: 25619834
[TBL] [Abstract][Full Text] [Related]
6. A role for the transcription factor HEY1 in glioblastoma.
Hulleman E; Quarto M; Vernell R; Masserdotti G; Colli E; Kros JM; Levi D; Gaetani P; Tunici P; Finocchiaro G; Baena RR; Capra M; Helin K
J Cell Mol Med; 2009 Jan; 13(1):136-46. PubMed ID: 18363832
[TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
[TBL] [Abstract][Full Text] [Related]
8. E6AP promotes the degradation of the PML tumor suppressor.
Louria-Hayon I; Alsheich-Bartok O; Levav-Cohen Y; Silberman I; Berger M; Grossman T; Matentzoglu K; Jiang YH; Muller S; Scheffner M; Haupt S; Haupt Y
Cell Death Differ; 2009 Aug; 16(8):1156-66. PubMed ID: 19325566
[TBL] [Abstract][Full Text] [Related]
9. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation.
Tatham MH; Geoffroy MC; Shen L; Plechanovova A; Hattersley N; Jaffray EG; Palvimo JJ; Hay RT
Nat Cell Biol; 2008 May; 10(5):538-46. PubMed ID: 18408734
[TBL] [Abstract][Full Text] [Related]
10. CRL4
Huang D; Liu C; Sun X; Sun X; Qu Y; Tang Y; Li G; Tong T
Biochem Biophys Res Commun; 2020 Aug; 529(2):127-132. PubMed ID: 32703400
[TBL] [Abstract][Full Text] [Related]
11. SUMOylation of HMGA2: selective destabilization of promyelocytic leukemia protein via proteasome.
Cao X; Clavijo C; Li X; Lin HH; Chen Y; Shih HM; Ann DK
Mol Cancer Ther; 2008 Apr; 7(4):923-34. PubMed ID: 18413806
[TBL] [Abstract][Full Text] [Related]
12. E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven lymphomagenesis.
Wolyniec K; Shortt J; de Stanchina E; Levav-Cohen Y; Alsheich-Bartok O; Louria-Hayon I; Corneille V; Kumar B; Woods SJ; Opat S; Johnstone RW; Scott CL; Segal D; Pandolfi PP; Fox S; Strasser A; Jiang YH; Lowe SW; Haupt S; Haupt Y
Blood; 2012 Jul; 120(4):822-32. PubMed ID: 22689861
[TBL] [Abstract][Full Text] [Related]
13. The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1.
Mathieu MG; Miles AK; Ahmad M; Buczek ME; Pockley AG; Rees RC; Regad T
Cell Death Dis; 2014 Feb; 5(2):e1061. PubMed ID: 24525737
[TBL] [Abstract][Full Text] [Related]
14. Methylation regulates HEY1 expression in glioblastoma.
Tsung AJ; Guda MR; Asuthkar S; Labak CM; Purvis IJ; Lu Y; Jain N; Bach SE; Prasad DVR; Velpula KK
Oncotarget; 2017 Jul; 8(27):44398-44409. PubMed ID: 28574840
[TBL] [Abstract][Full Text] [Related]
15. Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells.
Percherancier Y; Germain-Desprez D; Galisson F; Mascle XH; Dianoux L; Estephan P; Chelbi-Alix MK; Aubry M
J Biol Chem; 2009 Jun; 284(24):16595-16608. PubMed ID: 19380586
[TBL] [Abstract][Full Text] [Related]
16. β-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells.
Satow R; Shitashige M; Jigami T; Fukami K; Honda K; Kitabayashi I; Yamada T
Gastroenterology; 2012 Mar; 142(3):572-81. PubMed ID: 22155184
[TBL] [Abstract][Full Text] [Related]
17. PML regulates p53 stability by sequestering Mdm2 to the nucleolus.
Bernardi R; Scaglioni PP; Bergmann S; Horn HF; Vousden KH; Pandolfi PP
Nat Cell Biol; 2004 Jul; 6(7):665-72. PubMed ID: 15195100
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor alpha transcriptionally activates casein kinase 2 alpha: A pivotal regulator of promyelocytic leukaemia protein (PML) and AKT in oncogenesis.
Das N; Datta N; Chatterjee U; Ghosh MK
Cell Signal; 2016 Jun; 28(6):675-87. PubMed ID: 27012497
[TBL] [Abstract][Full Text] [Related]
19. A viral ubiquitin ligase has substrate preferential SUMO targeted ubiquitin ligase activity that counteracts intrinsic antiviral defence.
Boutell C; Cuchet-Lourenço D; Vanni E; Orr A; Glass M; McFarlane S; Everett RD
PLoS Pathog; 2011 Sep; 7(9):e1002245. PubMed ID: 21949651
[TBL] [Abstract][Full Text] [Related]
20. The role of PML ubiquitination in human malignancies.
Chen RH; Lee YR; Yuan WC
J Biomed Sci; 2012 Aug; 19(1):81. PubMed ID: 22935031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
